Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematology
•
Bone Marrow Failure
•
Benign Hematology
How do you approach an elderly patient with thymoma-related pure red cell aplasia who has failed multiple lines of treatment?
i.e. thymectomy, cyclosporine, steroids, cyclophosphamide, and rituxan; transfusion dependent
Related Questions
How is transferrin saturation a reliable indicator for any parameter if serum iron is not reliable?
Would you complete a bone marrow biopsy for an unexplained macrocytosis without anemia?
Would you anticoagulate a patient with splenic infarctions in the setting of CMV viremia?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
Can you use apixaban or rivaroxaban in case of dabigatran failure?
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
How do you manage me anticoagulation in a patient with May Thurner Syndrome, who does not have history of thrombosis, and becomes pregnant?
Is it true that a ferritin above 200 essentially rules out iron deficiency?